Larsimont D - Search Results

1

Reliability of tumor-infiltrating lymphocyte and tertiary lymphoid structure assessment in human breast cancer.

Buisseret L, Desmedt C, Garaud S, Fornili M, Wang X, Van den Eyden G, de Wind A, Duquenne S, Boisson A, Naveaux C, Rothé F, Rorive S, Decaestecker C, Larsimont D, Piccart-Gebhart M, Biganzoli E, Sotiriou C, Willard-Gallo K. Buisseret L, et al. Among authors: larsimont d. Mod Pathol. 2017 Sep;30(9):1204-1212. doi: 10.1038/modpathol.2017.43. Epub 2017 Jun 16. Mod Pathol. 2017. PMID: 28621322 Free article.

2

Interleukins-6 and -11 expression in primary breast cancer and subsequent development of bone metastases.

Sotiriou C, Lacroix M, Lespagnard L, Larsimont D, Paesmans M, Body JJ. Sotiriou C, et al. Among authors: larsimont d. Cancer Lett. 2001 Aug 10;169(1):87-95. doi: 10.1016/s0304-3835(01)00524-9. Cancer Lett. 2001. PMID: 11410329

3

Reliability of the tissue microarray based FISH for evaluation of the HER-2 oncogene in breast carcinoma.

Gancberg D, Di Leo A, Rouas G, Järvinen T, Verhest A, Isola J, Piccart MJ, Larsimont D. Gancberg D, et al. Among authors: larsimont d. J Clin Pathol. 2002 Apr;55(4):315-7. doi: 10.1136/jcp.55.4.315. J Clin Pathol. 2002. PMID: 11919221 Free PMC article.

4

Evaluation of HER-2/NEU protein expression in breast cancer by immunohistochemistry: an interlaboratory study assessing the reproducibility of HER-2/NEU testing.

Gancberg D, Järvinen T, di Leo A, Rouas G, Cardoso F, Paesmans M, Verhest A, Piccart MJ, Isola J, Larsimont D. Gancberg D, et al. Among authors: larsimont d. Breast Cancer Res Treat. 2002 Jul;74(2):113-20. doi: 10.1023/a:1016146130767. Breast Cancer Res Treat. 2002. PMID: 12186371

5

Predictive molecular markers in the adjuvant therapy of breast cancer: state of the art in the year 2002.

Di Leo A, Cardoso F, Durbecq V, Giuliani R, Mano M, Atalay G, Larsimont D, Sotiriou C, Biganzoli L, Piccart MJ. Di Leo A, et al. Among authors: larsimont d. Int J Clin Oncol. 2002 Aug;7(4):245-53. doi: 10.1007/s101470200036. Int J Clin Oncol. 2002. PMID: 12202978 Review.

6

Decrease of estrogen receptor expression and associated ERE-dependent transcription in MCF-7 breast cancer cells after oligomycin treatment.

Seo HS, Journé F, Larsimont D, Sotiriou C, Leclercq G. Seo HS, et al. Among authors: larsimont d. Steroids. 2003 Mar;68(3):257-69. doi: 10.1016/s0039-128x(02)00179-4. Steroids. 2003. PMID: 12628689

7

Correlation between complete response to anthracycline-based chemotherapy and topoisomerase II-alpha gene amplification and protein overexpression in locally advanced/metastatic breast cancer.

Cardoso F, Durbecq V, Larsimont D, Paesmans M, Leroy JY, Rouas G, Sotiriou C, Renard N, Richard V, Piccart MJ, Di Leo A. Cardoso F, et al. Among authors: larsimont d. Int J Oncol. 2004 Jan;24(1):201-9. Int J Oncol. 2004. PMID: 14654958

8

Topoisomerase-II alpha expression as a predictive marker in a population of advanced breast cancer patients randomly treated either with single-agent doxorubicin or single-agent docetaxel.

Durbecq V, Paesmans M, Cardoso F, Desmedt C, Di Leo A, Chan S, Friedrichs K, Pinter T, Van Belle S, Murray E, Bodrogi I, Walpole E, Lesperance B, Korec S, Crown J, Simmonds P, Perren TJ, Leroy JY, Rouas G, Sotiriou C, Piccart M, Larsimont D. Durbecq V, et al. Among authors: larsimont d. Mol Cancer Ther. 2004 Oct;3(10):1207-14. Mol Cancer Ther. 2004. PMID: 15486187 Clinical Trial.

9

Correlation between topoisomerase-IIalpha gene amplification and protein expression in HER-2 amplified breast cancer.

Durbecq V, Desmed C, Paesmans M, Cardoso F, Di Leo A, Mano M, Rouas G, Leroy JY, Sotiriou C, Piccart M, Larsimont D. Durbecq V, et al. Among authors: larsimont d. Int J Oncol. 2004 Nov;25(5):1473-9. doi: 10.3892/ijo.25.5.1473. Int J Oncol. 2004. PMID: 15492841

10

Potential predictive value of Bcl-2 for response to tamoxifen in the adjuvant setting of node-positive breast cancer.

Cardoso F, Paesmans M, Larsimont D, Durbecq V, Bernard-Marty C, Rouas G, Dolci S, Sotiriou C, Piccart MJ, Di Leo A. Cardoso F, et al. Among authors: larsimont d. Clin Breast Cancer. 2004 Dec;5(5):364-9. doi: 10.3816/cbc.2004.n.043. Clin Breast Cancer. 2004. PMID: 15585074

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

313 results

Search Page

Filters